Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × zimberelimab × Breast × Clear all

Phase

Status

Completed 2 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2 Gastrointestinal 2 Genitourinary 1 Endocrine 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Trastuzumab 26 Carboplatin 23 Paclitaxel 19 Capecitabine 19 pertuzumab 18 Docetaxel 17 Cyclophosphamide 17 pyrotinib 16 Letrozole 13 Drug Therapy 13 trastuzumab deruxtecan 11 Radiotherapy 11 Fulvestrant 11 sacituzumab govitecan 10 Standard of Care 10 pembrolizumab 9 palbociclib 9 exemestane 9 eribulin 9 dalpiciclib 9 Epirubicin 9 Anastrozole 9 abemaciclib 8 Specimen Handling 8 Doxorubicin 7 130-nm albumin-bound paclitaxel 7 toripalimab 6 ribociclib 6 Vinorelbine 6 Tamoxifen 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07134556 2026-01-23

ADJUNCT

MedSIR

Phase 2 Not yet recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡